Market Insights Consumer OTC Pharmaceuticals

Skin Treatment - Turkmenistan

Turkmenistan

Revenue in the Skin Treatment market amounts to US$117.40m in 2024. The market is expected to grow annually by 15.04% (CAGR 2024-2029).
In global comparison, most revenue is generated in the United States (US$4,184m in 2024).
In relation to total population figures, per person revenues of US$17.79 are generated in 2024.

Key regions: India, Canada, United States, United Kingdom, Philippines

Market

Region

Region comparison

Currency

Analyst Opinion

In the Skin Treatment market, the prevalence of skin diseases is a significant driving factor affecting the market growth. This is especially the case in emerging countries, where vehicle pollution, unhealthy lifestyles, and a lack of awareness of healthcare and skin diseases lead to a higher demand for skin treatment products.

Furthermore, the launch of effective medicine products also has a crucial impact on the market growth. However, the side effects of skin treatment products could cause life-threatening situations, which leads to a restriction of the development of the Skin Treatment market.

In 2022, the global Skin Treatment market reached US$17.94 billion and recovered from a slight decline in 2020 brought about by the COVID-19 pandemic. In the forecast period, the market is expected to reach a CAGR of around 3%.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.